Is Guardant Health (GH) At An Attractive Price After Recent Surge In Share Price?

Simply Wall St.01-11

If you are trying to figure out whether Guardant Health is attractively priced right now, you will want to look past the headlines and focus on what the valuation actually implies for you as a ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2602537264?lang=en_US&edition=fundamental","thumbnail":"https://images.simplywall.st/asset/industry/6032000-choice2-main-header/1585186864566","is_english":true,"pubTime":"2026-01-11 10:27","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2602537264","market":"us","top_or_hot":-1,"title":"Is Guardant Health (GH) At An Attractive Price After Recent Surge In Share Price?","media":"Simply Wall St.","content":"<div>\n<p>If you are trying to figure out whether Guardant Health is attractively priced right now, you will want to look past the headlines and focus on what the valuation actually implies for you as a ...</p>\n\n<a href=\"https://simplywall.st/stocks/us/healthcare/nasdaq-gh/guardant-health/news/is-guardant-health-gh-at-an-attractive-price-after-recent-su\">Source Link</a>\n\n</div>\n","source":"simplywall_highlight","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Is Guardant Health (GH) At An Attractive Price After Recent Surge In Share Price?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nIs Guardant Health (GH) At An Attractive Price After Recent Surge In Share Price?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-01-11 10:27 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://simplywall.st/stocks/us/healthcare/nasdaq-gh/guardant-health/news/is-guardant-health-gh-at-an-attractive-price-after-recent-su><strong>Simply Wall St.</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>If you are trying to figure out whether Guardant Health is attractively priced right now, you will want to look past the headlines and focus on what the valuation actually implies for you as a ...</p>\n\n<a href=\"https://simplywall.st/stocks/us/healthcare/nasdaq-gh/guardant-health/news/is-guardant-health-gh-at-an-attractive-price-after-recent-su\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"GH","symbol_name":"Guardant Health Inc.","start_time":0,"source_url":"https://simplywall.st/stocks/us/healthcare/nasdaq-gh/guardant-health/news/is-guardant-health-gh-at-an-attractive-price-after-recent-su","article_id":"2602537264","we_media_id":null,"thumbnails":["https://images.simplywall.st/asset/industry/6032000-choice2-main-header/1585186864566"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nasdaq-gh/guardant-health/news/is-guardant-health-gh-at-an-attractive-price-after-recent-su","rn_cache_url":null,"directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2602537264","pubTimestamp":1768098439,"columns":[],"sourceInfo":{"source_id":"simplywall_highlight","name":"Simply Wall St."},"weMediaInfo":null,"summary":"If you are trying to figure out whether Guardant Health is attractively priced right now, you will want to look past the headlines and focus on what the valuation actually implies for you as a shareholder.\nThe stock recently closed at US$110.17, with returns of 8.3% over the last 7 days, 8.7% over the last 30 days, 8.3% year to date, 200.1% over 1 year and 262.0% over 3 years, while the 5 year return sits at a 30.8% decline.\nRecent attention on Guardant Health has centered on its position in...","collect":0,"end_time":0,"defaultTopTitle":"simplywall.st","property":[],"viewcount":null,"language":"en","relate_stocks":{"GH":"Guardant Health Inc.","BK4196":"保健护理服务","BK4588":"碎股","BK4585":"ETF&股票定投概念","BK4535":"淡马锡持仓","DCF":"Dreyfus Alcentra Global Credit Income 2024 Target Term Fund, Inc","BK4551":"寇图资本持仓"},"translate_title":"Guardant Health(GH)近期股价飙升后的价格是否有吸引力？","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"DCF":1,"GH":1.5},"content_text":"If you are trying to figure out whether Guardant Health is attractively priced right now, you will want to look past the headlines and focus on what the valuation actually implies for you as a shareholder. The stock recently closed at US$110.17, with returns of 8.3% over the last 7 days, 8.7% over the last 30 days, 8.3% year to date, 200.1% over 1 year and 262.0% over 3 years, while the 5 year return sits at a 30.8% decline. Recent attention on Guardant Health has centered on its position in healthcare and diagnostics, with investors closely watching how its products and partnerships might influence future adoption in clinical settings. This backdrop helps explain why sentiment around the stock price has shifted enough to produce such wide differences between shorter term and longer term returns. On our valuation framework, Guardant Health scores 2 out of 6. This means it screens as undervalued on 2 of the 6 checks we use. Next, we will look at what different valuation methods say about this pricing, before finishing with a more complete way to think about its value story.  Guardant Health scores just 2/6 on our valuation checks. See what other red flags we found in the full valuation breakdown. AdvertisementApproach 1: Guardant Health Discounted Cash Flow (DCF) Analysis A Discounted Cash Flow model takes estimates of a company’s future cash flows and discounts them back to today’s dollars to suggest what the business might be worth now based on those projections. For Guardant Health, the model used is a 2 Stage Free Cash Flow to Equity approach. The latest twelve month free cash flow is a loss of about US$259.3 million. Analysts and extrapolated estimates see free cash flow moving to US$536.7 million by 2030, with a set of annual projections between 2026 and 2035 that move from negative to positive territory and then continue to grow, all expressed in US$. When these cash flows are discounted back using this DCF framework, the estimated intrinsic value comes out at about US$176.29 per share, compared with the recent share price of US$110.17. On this model, that gap translates to an implied 37.5% discount, which indicates that the shares screen as undervalued on a cash flow basis. Result: UNDERVALUED Our Discounted Cash Flow (DCF) analysis suggests Guardant Health is undervalued by 37.5%. Track this in your watchlist or portfolio, or discover 880 more undervalued stocks based on cash flows. GH Discounted Cash Flow as at Jan 2026 Head to the Valuation section of our Company Report for more details on how we arrive at this Fair Value for Guardant Health. Approach 2: Guardant Health Price vs Sales For a company like Guardant Health that is assessed here on revenue, the P/S ratio is a practical way to gauge what investors are paying for each dollar of sales, especially when earnings are not the main focus. In general, higher growth expectations and lower perceived risk can justify a higher “normal” or “fair” P/S ratio, while slower growth or higher risk usually argue for a lower multiple. Guardant Health currently trades on a P/S of 15.73x. That is well above the Healthcare industry average of 1.26x and also above the peer group average of 1.12x, which suggests the market is attaching a strong premium to its revenue base. Simply Wall St’s Fair Ratio is a proprietary estimate of what P/S might make sense for Guardant Health, given factors such as earnings growth, margins, industry, market cap and risk. This tailored view can be more informative than a simple comparison with peers or industry averages, because it tries to align the multiple with the company’s own profile. Guardant Health’s Fair Ratio is 6.68x, which is below the current 15.73x and points to shares that screen as expensive on this metric. Result: OVERVALUED NasdaqGS:GH P/S Ratio as at Jan 2026 P/S ratios tell one story, but what if the real opportunity lies elsewhere? Discover 1446 companies where insiders are betting big on explosive growth. Upgrade Your Decision Making: Choose your Guardant Health Narrative Earlier we mentioned that there is an even better way to understand valuation. On Simply Wall St’s Community page you can use Narratives to write your own story for Guardant Health by linking your view of its business with specific revenue, earnings and margin forecasts into a fair value that you can then compare with the current price. Because Narratives update automatically when new earnings, news or guidance arrive, you can see in real time how different investors’ views range from the more cautious fair value near US$47 to the more optimistic view near US$130, all within an accessible tool used by millions of investors to help decide whether they see the stock as priced above or below what they think it is worth. Do you think there's more to the story for Guardant Health? Head over to our Community to see what others are saying! NasdaqGS:GH 1-Year Stock Price Chart  This article by Simply Wall St is general in nature. We provide commentary based on historical data\n    and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your\n    financial situation. We aim to bring you long-term focused analysis driven by fundamental data.\n    Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.\n    Simply Wall St has no position in any stocks mentioned.New: Manage All Your Stock Portfolios in One PlaceWe've created the ultimate portfolio companion for stock investors, and it's free.• Connect an unlimited number of Portfolios and see your total in one currency• Be alerted to new Warning Signs or Risks via email or mobile• Track the Fair Value of your stocksTry a Demo Portfolio for FreeHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.0","shortVersion":"4.36.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2602537264","isCrawlerRequest":true}